{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T19:06:31Z","timestamp":1778526391990,"version":"3.51.4"},"reference-count":40,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Microbial Drug Resistance"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:p>Data on Point Prevalence Surveys (PPSs) in India are limited yet. We report findings of a PPS conducted in a core \u201cNational Antimicrobial Consumption Network site\u201d under National Centre for Disease Control - WHO project \u201cPoint prevalence survey of antimicrobial consumption at healthcare facilities.\u201d A cross-sectional survey was conducted as per the \u201cWHO methodology for PPS on antibiotic use in hospitals\u201d in a tertiary care hospital in India in December 2021. Data were collected using predesigned and pretested questionnaire in separate hospital, ward, and patient forms. Eight hundred two inpatients (excluding ICUs) were covered out of whom 299 (37.3%) were on antibiotics with 11.7% receiving 3 or more antibiotics. Surgical prophylaxis (SP) (42.5%) and community acquired infections (32.8%) were the most common indications for antibiotic use. Of the patients, 92.5% received SP for more than 24\u2009hrs. Most commonly prescribed antibiotics were penicillins with beta-lactamase inhibitors (22.3%). Of the total antibiotic prescriptions, 81.5% were from WHO essential medicines list and 12% from \u201cnot recommended\u201d WHO AWaRe classification. Of the antibiotic prescriptions, 84.6% were parenteral. Few prescriptions complied with standard treatment guidelines (1.9%), documented indication for antibiotic use (11.6%), and stop\/review date (4.4%) in notes. Double anaerobic cover accounted for 6.8% of the total prescriptions. Some identified areas for improvement were: formulation of hospital antibiotic guidelines, promoting culture of sending cultures, improvement in surgical antibiotic prophylaxis, decreasing use of antibiotic combinations and double anaerobic cover, fostering IV to oral switch of antibiotics, and ensuring effective communication among health care workers by documenting adequate information in medical notes.<\/jats:p>","DOI":"10.1089\/mdr.2022.0170","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T14:01:56Z","timestamp":1674136916000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["WHO-Point Prevalence Survey of Antibiotic Use Among Inpatients at a Core National Antimicrobial Consumption Network Site in North India: Findings and Implications"],"prefix":"10.1177","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7209-098X","authenticated-orcid":false,"given":"Niti","family":"Mittal","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Pt. B. D. Sharma Postgraduate Institute of Medical Sciences, Rohtak, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Mittal","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pt. B. D. Sharma Postgraduate Institute of Medical Sciences, Rohtak, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidhi","family":"Goel","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Pt. B. D. Sharma Postgraduate Institute of Medical Sciences, Rohtak, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aparna","family":"Parmar","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Pt. B. D. Sharma Postgraduate Institute of Medical Sciences, Rohtak, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arti","family":"Bahl","sequence":"additional","affiliation":[{"name":"National Center for Disease Control (NCDC), New Delhi, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suneet","family":"Kaur","sequence":"additional","affiliation":[{"name":"National Center for Disease Control (NCDC), New Delhi, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavita R.","family":"Gudibanda","sequence":"additional","affiliation":[{"name":"National Center for Disease Control (NCDC), New Delhi, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vibhor","family":"Dudhraj","sequence":"additional","affiliation":[{"name":"National Center for Disease Control (NCDC), New Delhi, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujeet K.","family":"Singh","sequence":"additional","affiliation":[{"name":"National Center for Disease Control (NCDC), New Delhi, India."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,1,17]]},"reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"crossref","unstructured":"Antimicrobial resistance collaborators. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet 2022;399:629\u2013655.","DOI":"10.1016\/S0140-6736(21)02724-0"},{"key":"e_1_3_6_3_2","unstructured":"World Health Organization. WHO's first global report on antibiotic resistance reveals serious worldwide threat to public health. Available from: http:\/\/www.who.int\/mediacentre\/news\/releases\/2014\/amr-report\/en\/ [Last accessed: December 2021]."},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1717295115"},{"key":"e_1_3_6_5_2","unstructured":"Fomda BA Khan A Zahoor D. NDM-1 (New Delhi metallo beta lactamase-1) producing Gram-negative bacilli: Emergence and clinical implications. Indian J Med Res 2014;140:672\u2013678."},{"key":"e_1_3_6_6_2","unstructured":"Global Action Plan on Antimicrobial Resistance WHO. 2015. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/193736 [Last accessed: December 2021]."},{"issue":"3","key":"e_1_3_6_7_2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1473-3099(18)30060-4","article-title":"WHO global antimicrobial resistance surveillance system early implementation 2016\u20132017","volume":"18","author":"Tornimbene B","year":"2018","unstructured":"Tornimbene B, , Eremin S, , Escher M, et al. WHO global antimicrobial resistance surveillance system early implementation 2016\u20132017. Lancet Infect Dis, 2018; 18(3):241\u2013242; doi: 10.1016\/S1473-3099(18)30060-4","journal-title":"Lancet Infect Dis"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70318-9"},{"key":"e_1_3_6_9_2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.12688\/wellcomeopenres.12527.1","article-title":"AMR surveillance in low and middle-income settings - a roadmap for participation in the global antimicrobial surveillance system (GLASS)","volume":"2","author":"Seale AC","year":"2017","unstructured":"Seale AC, , Gordon NC, , Islam J, et al. AMR surveillance in low and middle-income settings - a roadmap for participation in the global antimicrobial surveillance system (GLASS). Wellcome Open Res, 2017; 2:92; doi: 10.12688\/wellcomeopenres.12527.1","journal-title":"Wellcome Open Res"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.16.181743"},{"key":"e_1_3_6_11_2","unstructured":"Ministry of Health and Family Welfare Government of India. National Action Plan on AMR (NAP-AMR) 2017\u20132021. 2017. Available from: https:\/\/ncdc.gov.in\/WriteReadData\/l892s\/File645.pdf [Last accessed: February 2022]."},{"key":"e_1_3_6_12_2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4103\/ijmr.IJMR_147_18","article-title":"Policy document on antimicrobial stewardship practices in India","volume":"149","author":"Walia K","year":"2019","unstructured":"Walia K, , Ohri VC, , Madhumathi J, et al. Policy document on antimicrobial stewardship practices in India. Indian J Med Res, 2019; 149:180\u2013184; doi: 10.4103\/ijmr.IJMR_147_18","journal-title":"Indian J Med Res"},{"key":"e_1_3_6_13_2","unstructured":"Chandy SJ Michael JS Veeraraghavan B et al. ICMR programme on antibiotic stewardship prevention of infection & control (ASPIC). Indian J Med Res 2014;139:226\u2013230."},{"key":"e_1_3_6_14_2","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.3389\/fphar.2018.01156","article-title":"Antimicrobial medicines consumption in eastern Europe and Central Asia \u2013 an updated cross-national study and assessment of quantitative metrics for policy action","volume":"9","author":"Robertson J","year":"2019","unstructured":"Robertson J, , Iwamoto K, , Hoxha I, et al. Antimicrobial medicines consumption in eastern Europe and Central Asia \u2013 an updated cross-national study and assessment of quantitative metrics for policy action. Front Pharmacol, 2019; 9:1156; doi: 10.3389\/fphar.2018.01156","journal-title":"Front Pharmacol"},{"key":"e_1_3_6_15_2","unstructured":"WHO. WHO Methodology for Point Prevalence Survey on Antibiotic Use in Hospitals Version 1.1. 2018. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/280063\/WHO-EMP-IAU-2018.01-eng.pdf [Last accessed: December 2021]."},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2021.1898946"},{"key":"e_1_3_6_17_2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jiph.2014.07.001","article-title":"A multicenter point-prevalence survey of antibiotic use in 13 Chinese hospitals","volume":"8","author":"Xiea D","year":"2015","unstructured":"Xiea D, , Xianga L, , Lia R, et al. A multicenter point-prevalence survey of antibiotic use in 13 Chinese hospitals. J Infect Public Health, 2015; 8:55\u201361; doi: 10.1016\/j.jiph.2014.07.001","journal-title":"J Infect Public Health"},{"issue":"3","key":"e_1_3_6_18_2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jhin.2018.03.005","article-title":"The first multi-centre point-prevalence survey in four Japanese university hospitals","volume":"99","author":"Morioka H","year":"2018","unstructured":"Morioka H, , Nagao M, , Yoshihara S, et al. The first multi-centre point-prevalence survey in four Japanese university hospitals. J Hosp Infect, 2018; 99(3):325\u2013331; doi: 10.1016\/j.jhin.2018.03.005","journal-title":"J Hosp Infect"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2019.1581063"},{"issue":"6","key":"e_1_3_6_20_2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/14787210.2021.1834852","article-title":"A multicentre point prevalence survey of hospital antibiotic prescribing and quality indices in the Kurdistan Regional Government of Northern Iraq: The need for urgent action","volume":"19","author":"Kurdi A","year":"2021","unstructured":"Kurdi A, , Hasan AJ, , Baker KI, et al. A multicentre point prevalence survey of hospital antibiotic prescribing and quality indices in the Kurdistan Regional Government of Northern Iraq: The need for urgent action. Expert Rev Anti Infect Ther, 2021; 19(6):805\u2013814; doi: 10.1080\/14787210.2021.1834852","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"6","key":"e_1_3_6_21_2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s40266-019-00651-2","article-title":"A Point Prevalence Study of Antimicrobial Use and Practice Among Nursing Homes in Singapore","volume":"36","author":"Selcuk A","year":"2019","unstructured":"Selcuk A, , Yap KZ, , Wong CL, et al. A Point Prevalence Study of Antimicrobial Use and Practice Among Nursing Homes in Singapore. Drugs Aging, 2019; 36(6):559\u2013570; doi: 10.1007\/s40266-019-00651-2","journal-title":"Drugs Aging"},{"key":"e_1_3_6_22_2","doi-asserted-by":"crossref","first-page":"e619","DOI":"10.1016\/S2214-109X(18)30186-4","article-title":"Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: Results of an internet-based global point prevalence survey","volume":"6","author":"Versporten A","year":"2018","unstructured":"Versporten A, , Zarb P, , Caniaux I, et al. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: Results of an internet-based global point prevalence survey. Lancet Glob Health, 2018; 6:e619\u2013e629; doi: 10.1016\/S2214-109X(18)30347-4","journal-title":"Lancet Glob Health"},{"issue":"6","key":"e_1_3_6_23_2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2165\/11591180-000000000-00000","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): Value of a point-prevalence survey of antimicrobial use across Europe","volume":"71","author":"Zarb P","year":"2011","unstructured":"Zarb P, , Goossens H. European Surveillance of Antimicrobial Consumption (ESAC): Value of a point-prevalence survey of antimicrobial use across Europe. Drugs, 2011; 71(6):745\u2013755; doi: 10.2165\/11591180-000000000-00000","journal-title":"Drugs"},{"key":"e_1_3_6_24_2","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/jac\/dkaa533","article-title":"A multicentre point prevalence survey (PPS) of antimicrobial use amongst admitted patients in tertiary care centres in India","volume":"76","author":"Panditrao A","year":"2021","unstructured":"Panditrao A, , Shafiq N, , Chatterjee S, et al. A multicentre point prevalence survey (PPS) of antimicrobial use amongst admitted patients in tertiary care centres in India. J Antimicrob Chemother, 2021; 76:1094\u20131101; doi: 10.1093\/jac\/dkaa533","journal-title":"J Antimicrob Chemother"},{"key":"e_1_3_6_25_2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhin.2019.05.014","article-title":"Variations in antibiotic use across India: Multi-centre study through global point prevalence survey","volume":"103","author":"Singh SK","year":"2019","unstructured":"Singh SK, , Sengupta S, , Antony R, et al. Variations in antibiotic use across India: Multi-centre study through global point prevalence survey. J Hosp Infect, 2019; 103:280\u2013283; doi: 10.1016\/j.jhin.2019.05.014","journal-title":"J Hosp Infect"},{"key":"e_1_3_6_26_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/antibiotics6030019","article-title":"Point prevalence surveys of antimicrobial use among hospitalized children in six hospitals in India in 2016","volume":"6","author":"Gandra S","year":"2017","unstructured":"Gandra S, , Singh S, , Jinka D, et al. Point prevalence surveys of antimicrobial use among hospitalized children in six hospitals in India in 2016. Antibiotics (Basel), 2017; 6:19\u201327; doi: 10.3390\/antibiotics6030019","journal-title":"Antibiotics (Basel)"},{"key":"e_1_3_6_27_2","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.4103\/jfmpc.jfmpc_430_19","article-title":"A pilot point prevalence study of antimicrobial drugs in indoor patients of a teaching hospital in Central India","volume":"8","author":"Najmi A","year":"2019","unstructured":"Najmi A, , Sadasivam B, , Jhaj R, et al. A pilot point prevalence study of antimicrobial drugs in indoor patients of a teaching hospital in Central India. J Family Med Prim Care, 2019; 8:2212\u20132217; doi: 10.4103\/jfmpc.jfmpc_430_19","journal-title":"J Family Med Prim Care"},{"key":"e_1_3_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2018.03.017"},{"key":"e_1_3_6_29_2","unstructured":"Goossens H Nathwani D. 2019. Global Point Prevalence Survey of Antimicrobial Consumption and Resistance (2019 GLOBAL-PPS). Available from: http:\/\/www.global-pps.com\/wp-content\/uploads\/2019\/02\/Global-PPS-2019-protocol.pdf [Last accessed: January 2022]."},{"key":"e_1_3_6_30_2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4103\/ijmm.IJMM_17_133","article-title":"Exploring the prescribing behaviours and the mind of antibiotic prescribers is critical for a successful antibiotic stewardship programme: Results of a survey from Eastern India","volume":"35","author":"Ravi N","year":"2017","unstructured":"Ravi N, , Laha A, , Hmar L, et al. Exploring the prescribing behaviours and the mind of antibiotic prescribers is critical for a successful antibiotic stewardship programme: Results of a survey from Eastern India. Indian J Med Microbiol, 2017; 35:299\u2013301; doi: 10.4103\/ijmm.IJMM_17_133","journal-title":"Indian J Med Microbiol"},{"key":"e_1_3_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2019.01.013"},{"issue":"3","key":"e_1_3_6_32_2","first-page":"128","article-title":"Point prevalence survey of antibiotic use and resistance at a referral hospital in Kenya: Findings and implications","volume":"6","author":"Okoth C","year":"2018","unstructured":"Okoth C, , Opanga S, , Okalebo F, et al. Point prevalence survey of antibiotic use and resistance at a referral hospital in Kenya: Findings and implications. Hosp Pract 1995, 2018; 6(3):128\u2013136; doi: 10.1080\/21548331.2018.1464872","journal-title":"Hosp Pract 1995"},{"key":"e_1_3_6_33_2","unstructured":"Global Guidelines for the Prevention of Surgical Site Infection WHO. Available from: https:\/\/www.who.int\/gpsc\/global-guidelines-web.pdf [Last accessed: March 2022]."},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp120568"},{"key":"e_1_3_6_35_2","doi-asserted-by":"publisher","DOI":"10.1086\/676022"},{"key":"e_1_3_6_36_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a1924"},{"issue":"1","key":"e_1_3_6_37_2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jhin.2016.08.010","article-title":"A point-prevalence survey of healthcare-associated infections in fifty-two Chinese hospitals","volume":"95","author":"Chen Y","year":"2017","unstructured":"Chen Y, , Zhao J, , Shan X, et al. A point-prevalence survey of healthcare-associated infections in fifty-two Chinese hospitals. J Hosp Infect, 2017; 95(1):105\u2013111; doi: 10.1016\/j.jhin.2016.08.010","journal-title":"J Hosp Infect"},{"issue":"1","key":"e_1_3_6_38_2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13756-020-00722-9","article-title":"Point-prevalence survey of hospital acquired infections in three acute care hospitals in Northern Nigeria","volume":"9","author":"Abubakar U.","year":"2020","unstructured":"Abubakar U. Point-prevalence survey of hospital acquired infections in three acute care hospitals in Northern Nigeria. Antimicrob Resist Infect Control, 2020; 9(1):63; doi: 10.1186\/s13756-020-00722-9","journal-title":"Antimicrob Resist Infect Control"},{"issue":"4","key":"e_1_3_6_39_2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ajic.2018.09.025","article-title":"A multicenter point-prevalence survey of healthcare-associated infections in Pakistan: Findings and implications","volume":"47","author":"Saleem Z","year":"2019","unstructured":"Saleem Z, , Hassali MA, , Godman B, et al. A multicenter point-prevalence survey of healthcare-associated infections in Pakistan: Findings and implications. Am J Infect Control, 2019; 47(4):421\u2013424; doi: 10.1016\/j.ajic.2018.09.025","journal-title":"Am J Infect Control"},{"key":"e_1_3_6_40_2","unstructured":"WHO 2021 AwaRe classification. Available from: https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification [Last accessed: March 2022]."},{"key":"e_1_3_6_41_2","unstructured":"AWaRe policy brief. Available from: https:\/\/adoptaware.org\/assets\/pdf\/aware_policy_brief.pdf [Last accessed: March 2022]."}],"container-title":["Microbial Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/mdr.2022.0170","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2022.0170","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2022.0170","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:40:34Z","timestamp":1777668034000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/mdr.2022.0170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1089\/mdr.2022.0170"],"URL":"https:\/\/doi.org\/10.1089\/mdr.2022.0170","relation":{},"ISSN":["1076-6294","1931-8448"],"issn-type":[{"value":"1076-6294","type":"print"},{"value":"1931-8448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]}}}